Position in AZN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$93,866,464
New position
Shares Held
475,948
first reported quarter
Ownership
0.031%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026HighTower Advisors, LLC holds $4,563,556,722 across 16 Drug Manufacturers - General names. AZN ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,484,201 | $2,562,758,092 | |
| 2 | MRK |
Merck & Co., Inc.
|
3,635,404 | $437,302,747 | |
| 3 | LLY |
ELI LILLY & Co
|
440,797 | $405,431,856 | |
| 4 | ABBV |
AbbVie Inc.
|
1,658,024 | $360,603,639 | |
| 5 | AMGN |
Amgen Inc
|
820,320 | $288,629,592 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,450,177 | $202,111,168 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
475,948 | $93,866,464 | |
| 8 | PFE |
Pfizer Inc
|
2,648,143 | $74,359,855 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $93,866,464 | 475,948 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||